Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt/β-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression

References

• Wang TS, Sosa JA. Thyroid surgery for differentiated thyroid cancer - recent advances and future directions. Nat Rev Endocrinol. 2018;14(11):670–683.
   PubMed Web of Science ®Google Scholar
• Leboulleux S, Tuttle RM, Pacini F, et al. Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance? Lancet Diabetes Endocrinol. 2016;4(11):933–942.
   PubMed Web of Science ®Google Scholar
• Lim AM, Solomon BJ. Immunotherapy for anaplastic thyroid carcinoma. J Clin Oncol. 2020;38(23):2603–2604.
   PubMed Web of Science ®Google Scholar
• Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. N at Rev Endocrinol. 2016;12(11):646–653.
   PubMed Web of Science ®Google Scholar
• Tiedje V, Fagin JA. Therapeutic breakthroughs for metastatic thyroid cancer. Nat Rev Endocrinol. 2020;16(2):77–78.
   PubMed Web of Science ®Google Scholar
• Fagin JA, Wells SA Jr. Biologic and clinical perspectives on thyroid cancer. N Engl J Med. 2016;375(11):1054–1067.
   PubMed Web of Science ®Google Scholar
• Lin RX, Yang SL, Jia Y, et al. Epigenetic regulation of papillary thyroid carcinoma by long non-coding RNAs. Semin Cancer Biol. 2021. DOI:10.1016/j.semcancer.2021.03.027
   Web of Science ®Google Scholar
• Vaccarella S, Lortet-Tieulent J, Colombet M, et al. Global patterns and trends in incidence and mortality of thyroid cancer in children and adolescents: a population-based study. Lancet Diabetes Endocrinol. 2021;9(3):144–152.
   PubMed Web of Science ®Google Scholar
• Fallahi P, Ferrari SM, Elia G, et al. Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin. Semin Cancer Biol. 2020; DOI:10.1016/j.semcancer.2020.06.013.
   Web of Science ®Google Scholar
• How CW, Ong YS, Low SS, et al. How far have we explored fungi to fight cancer? Semin Cancer Biol. 2021. DOI:10.1016/j.semcancer.2021.03.009
   PubMed Web of Science ®Google Scholar
• He L, Man C, Xiang S, et al. Circular RNAs’ cap-independent translation protein and its roles in carcinomas. Mol Cancer. 2021;20(1):119.
   PubMed Web of Science ®Google Scholar
• Shen H, Liu B, Xu J, et al. Circular RNAs: characteristics, biogenesis, mechanisms and functions in liver cancer. J Hematol Oncol. 2021;14(1):134.
   PubMed Web of Science ®Google Scholar
• Yang Y, Lei W, Jiang S, et al. CircRNAs: decrypting the novel targets of fibrosis and aging. Ageing Res Rev. 2021;70:101390.
   PubMed Web of Science ®Google Scholar
• van Zonneveld AJ, Kolling M, Bijkerk R, et al. Circular RNAs in kidney disease and cancer. Nat Rev Nephrol. 2021;17(12):814–826.
   PubMed Web of Science ®Google Scholar
• Zhou WY, Cai ZR, Liu J, et al. Circular RNA: metabolism, functions and interactions with proteins. Mol Cancer. 2020;19(1):172.
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang K, Tan S, et al. Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies. Mol Cancer. 2021;20(1):13.
   PubMed Web of Science ®Google Scholar
• Tan KL, Chia WC, How CW, et al. Benchtop isolation and characterisation of small extracellular vesicles from human mesenchymal stem cells. Mol Biotechnol. 2021;63(9):780–791.
   PubMed Web of Science ®Google Scholar
• Long F, Lin Z, Li L, et al. Comprehensive landscape and future perspectives of circular RNAs in colorectal cancer. Mol Cancer. 2021;20(1):26.
   PubMed Web of Science ®Google Scholar
• Goodall GJ, Wickramasinghe VO. RNA in cancer. Nat Rev Cancer. 2020;21(1):22–36.
   PubMed Web of Science ®Google Scholar
• Gokool A, Loy CT, Halliday GM, et al. Circular RNAs: the brain transcriptome comes full circle. Trends Neurosci. 2020;43(10):752–766.
   PubMed Web of Science ®Google Scholar
• Ma S, Kong S, Wang F, et al. CircRNAs: biogenesis, functions, and role in drug-resistant Tumours. Mol Cancer. 2020;19(1):119.
   PubMed Web of Science ®Google Scholar
• Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21(8):475–490.
   PubMed Web of Science ®Google Scholar
• Wen G, Zhou T, Gu W. The potential of using blood circular RNA as liquid biopsy biomarker for human diseases. Protein Cell. 2020. DOI:10.1007/s13238-020-00799-3
   Web of Science ®Google Scholar
• Li G, Guo BY, Wang HD, et al. CircRNA hsa_circ_0014130 function as a miR-132-3p sponge for playing oncogenic roles in bladder cancer via upregulating KCNJ12 expression. Cell Biol Toxicol. 2021. DOI:10.1007/s10565-021-09668-z
   Web of Science ®Google Scholar
• Zhang X, Wu N, Wang J. Hsa-circ_0058106 induces EMT and metastasis in laryngeal cancer via sponging miR-153 and inducing Twist1 nuclear translocation. Cell Oncol (Dordr). 2021. DOI:10.1007/s13402-021-00644-7
   Web of Science ®Google Scholar
• Cai Y, Zhao X, Chen D, et al. circ-NOL10 regulated by MTDH/CASC3 inhibits breast cancer progression and metastasis via multiple miRNAs and PDCD4. Mol Ther Nucleic Acids. 2021;26:773–786.
   PubMedGoogle Scholar
• Ghetti M, Vannini I, Storlazzi CT, et al. Linear and circular PVT1 in hematological malignancies and immune response: two faces of the same coin. Mol Cancer. 2020;19(1):69.
   PubMed Web of Science ®Google Scholar
• Traversa D, Simonetti G, Tolomeo D, et al. Unravelling similarities and differences in the role of circular and linear PVT1 in cancer and human disease. Br J Cancer. 2021. DOI:10.1038/s41416-021-01584-7
   PubMed Web of Science ®Google Scholar
• Yu F, Lin Y, Ai MM, et al. Knockdown of circular RNA hsa_circ_PVT1 inhibited laryngeal cancer progression via preventing wnt4/beta-Catenin signaling pathway activation. Front Cell Dev Biol. 2021;9:658115.
   PubMed Web of Science ®Google Scholar
• Li X, Zhang Z, Jiang H, et al. Circular RNA circPVT1 promotes proliferation and invasion through sponging miR-125b and activating E2F2 signaling in non-small cell lung cancer. Cell Physiol Biochem. 2018;51(5):2324–2340.
   PubMedGoogle Scholar
• Chen J, Li Y, Zheng Q, et al. Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer. Cancer Lett. 2017;388:208–219.
   PubMed Web of Science ®Google Scholar
• Zheng Z, Chen Z, Zhong Q, et al. CircPVT1 promotes progression in clear cell renal cell carcinoma by sponging miR-145-5p and regulating TBX15 expression. Cancer Sci. 2021;112(4):1443–1456.
   PubMed Web of Science ®Google Scholar
• Li M, Chi C, Zhou L, et al. Circular PVT1 regulates cell proliferation and invasion via miR-149-5p/FOXM1 axis in ovarian cancer. J Cancer. 2021;12(2):611–621.
   PubMed Web of Science ®Google Scholar
• Wang H, Wei M, Kang Y, et al. Circular RNA circ_PVT1 induces epithelial-mesenchymal transition to promote metastasis of cervical cancer. Aging (Albany NY). 2020;12(20):20139–20151.
   PubMedGoogle Scholar
• Bian Q. Circular RNA PVT1 promotes the invasion and epithelial-mesenchymal transition of breast cancer cells through serving as a competing endogenous RNA for miR-204-5p. Onco Targets Ther. 2019;12:11817–11826.
   PubMed Web of Science ®Google Scholar
• Ishola AA, Chien CS, Yang YP, et al. Oncogenic circRNA hsa_circ_0000190 modulates EGFR/ERK pathway in promoting NSCLC. Cancer Res. 2021; DOI:10.1158/0008-5472.CAN-21-1473.
   PubMedGoogle Scholar
• Chen SW, Zhu SQ, Pei X, et al. Cancer cell-derived exosomal circUSP7 induces CD8(+) T cell dysfunction and anti-PD1 resistance by regulating the miR-934/SHP2 axis in NSCLC. Mol Cancer. 2021;20(1):144.
   PubMed Web of Science ®Google Scholar
• Li J, Gao X, Zhang Z, et al. CircCD44 plays oncogenic roles in triple-negative breast cancer by modulating the miR-502-5p/KRAS and IGF2BP2/Myc axes. Mol Cancer. 2021;20(1):138.
   PubMed Web of Science ®Google Scholar
• Mao W, Wang K, Xu B, et al. ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma. Mol Cancer. 2021;20(1):142.
   PubMed Web of Science ®Google Scholar
• Rong D, Wu F, Lu C, et al. m6A modification of circHPS5 and hepatocellular carcinoma progression through HMGA2 expression. Mol Ther Nucleic Acids. 2021;26:637–648.
   PubMedGoogle Scholar
• Yin H, Chen L, Piao S, et al. M6A RNA methylation-mediated RMRP stability renders proliferation and progression of non-small cell lung cancer through regulating TGFBR1/SMAD2/SMAD3 pathway. Cell Death Differ. 2021. DOI:10.1038/s41418-021-00888-8
   Web of Science ®Google Scholar
• Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(D1):D92–7.
   PubMed Web of Science ®Google Scholar
• Salvatore D, Santoro M, Schlumberger M. The importance of the RET gene in thyroid cancer and therapeutic implications. Nat Rev Endocrinol. 2021;17(5):296–306.
   PubMed Web of Science ®Google Scholar
• Fallahi P, Ferrari SM, Galdiero MR, et al. Molecular targets of tyrosine kinase inhibitors in thyroid cancer. Semin Cancer Biol. 2020. DOI:10.1016/j.semcancer.2020.11.013
   Web of Science ®Google Scholar
• Dsa M, Zhang L, Durante C, et al. Contemporary debates in adult papillary thyroid cancer management. Endocr Rev. 2019;40(6):1481–1499.
   PubMed Web of Science ®Google Scholar
• Pstrag N, Ziemnicka K, Bluyssen H, et al. Thyroid cancers of follicular origin in a genomic light: in-depth overview of common and unique molecular marker candidates. Mol Cancer. 2018;17(1):116.
   PubMed Web of Science ®Google Scholar
• Lauretti E, Dabrowski K, Pratico D. The neurobiology of non-coding RNAs and alzheimer’s disease pathogenesis: pathways, mechanisms and translational opportunities. Ageing Res Rev. 2021;71:101425.
   PubMed Web of Science ®Google Scholar
• Luo Q, Guo F, Fu Q, et al. hsa_circ_0001018 promotes papillary thyroid cancer by facilitating cell survival invasion, G1/S cell cycle progression, and repressing cell apoptosis via crosstalk with miR-338-3p and SOX4. Mol Ther Nucleic Acids. 2021;24:591–609.
   PubMedGoogle Scholar
• Chu, J , Tao, L , and Yao, T. Circular RNA circRUNX1 promotes papillary thyroid cancer progression and metastasis by sponging MiR-296-3p and regulating DDHD2 expression. Cell Death Dis. 2021;122: 112.
   PubMedGoogle Scholar
• Ye M, Hou H, Shen M, et al. Circular RNA circFOXM1 plays a role in papillary thyroid carcinoma by sponging miR-1179 and regulating HMGB1 expression. Mol Ther Nucleic Acids. 2020;19:741–750.
   PubMedGoogle Scholar
• Yu F, Yu C, Li F, et al. Wnt/beta-catenin signaling in cancers and targeted therapies. Signal Transduct Target Ther. 2021;6(1):307.
   PubMed Web of Science ®Google Scholar
• Tewari D, Bawari S, Sharma S, et al. Targeting the crosstalk between canonical Wnt/beta-catenin and inflammatory signaling cascades: a novel strategy for cancer prevention and therapy. Pharmacol Ther. 2021;227:107876.
   PubMed Web of Science ®Google Scholar
• Dai W, Jin X, Han L, et al. Exosomal lncRNA DOCK9-AS2 derived from cancer stem cell-like cells activated Wnt/beta-catenin pathway to aggravate stemness, proliferation, migration, and invasion in papillary thyroid carcinoma. Cell Death Dis. 2020;11(9):743.
   PubMed Web of Science ®Google Scholar
• Ma J, Huang X, Li Z, et al. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β-catenin pathway. J Cell Physiol. 2019;234(10):17739–17748.
   PubMed Web of Science ®Google Scholar
• Bi W, Huang J, Nie C, et al. CircRNA circRNA_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1-dependent activation of beta-catenin pathway. J Exp Clin Cancer Res. 2018;37(1):275.
   PubMed Web of Science ®Google Scholar
• Gu H, Xu Z, Zhang J, et al. circ_0038718 promotes colon cancer cell malignant progression via the miR-195-5p/Axin2 signaling axis and also effect Wnt/beta-catenin signal pathway. BMC Genomics. 2021;22(1):768.
   PubMed Web of Science ®Google Scholar
• Xi J, Xi Y, Zhang Z, et al. Hsa_circ_0060937 accelerates non-small cell lung cancer progression via modulating miR-195-5p/HMGB3 pathway. Cell Cycle. 2021;20(19):2040–2052.
   PubMed Web of Science ®Google Scholar
• Zhou M, Wang Y, Zhang C, et al. MicroRNA‑195‑5p suppresses the proliferation, migration, invasion and epithelial‑mesenchymal transition of laryngeal cancer cells in vitro by targeting E2F3. Exp Ther Med. 2021;22(4):1078.
   PubMed Web of Science ®Google Scholar
• Shen D, Li J, Tao K, et al. Long non-coding RNA MCM3AP antisense RNA 1 promotes non-small cell lung cancer progression through targeting microRNA-195-5p. Bioengineered. 2021;12(1):3525–3538.
   PubMed Web of Science ®Google Scholar
• Yan B, Ren Z, Sun J, et al. IGF2-AS knockdown inhibits glycolysis and accelerates apoptosis of gastric cancer cells through targeting miR-195/CREB1 axis. Biomed Pharmacother. 2020;130:110600.
   PubMed Web of Science ®Google Scholar
• Liu S, Li B, Li Y, et al. Circular RNA circ_0000228 promotes the malignancy of cervical cancer via microRNA-195-5p/ lysyl oxidase-like protein 2 axis. Bioengineered. 2021;12(1):4397–4406.
   PubMed Web of Science ®Google Scholar
• Li S, Lv C, Li J, et al. LncRNA LINC00473 promoted colorectal cancer cell proliferation and invasion by targeting miR-195 expression. Am J Transl Res. 2021;13(6):6066–6075.
   PubMed Web of Science ®Google Scholar
• Wu J, Xu W, Ma L, et al. Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer. Aging (Albany NY). 2021;13(14):18191–18222.
   PubMedGoogle Scholar
• Wang A, Zhang T, Wei W, et al. The Long Noncoding RNA LINC00665 facilitates c-myc transcriptional activity via the miR-195-5p MYCBP axis to promote progression of lung adenocarcinoma. Front Oncol. 2021;11:666551.
   PubMed Web of Science ®Google Scholar
• Yang B, Li L, Tong G, et al. Circular RNA circ_001422 promotes the progression and metastasis of osteosarcoma via the miR-195-5p/FGF2/PI3K/Akt axis. J Exp Clin Cancer Res. 2021;40(1):235.
   PubMed Web of Science ®Google Scholar
• Li C, Zhu L, Fu L, et al. CircRNA NRIP1 promotes papillary thyroid carcinoma progression by sponging mir-195-5p and modulating the P38 MAPK and JAK/STAT pathways. Diagn Pathol. 2021;16(1):93.
   PubMed Web of Science ®Google Scholar
• Xu J, Li Z, Su Q, et al. Suppression of long noncoding RNA LINC00324 restricts cell proliferation and invasion of papillary thyroid carcinoma through downregulation of TRIM29 via upregulating microRNA-195-5p. Aging (Albany NY). 2020;12(24):26000–26011.
   PubMedGoogle Scholar
• Gui X, Li Y, Zhang X, et al. Circ_LDLR promoted the development of papillary thyroid carcinoma via regulating miR-195-5p/LIPH axis. Cancer Cell Int. 2020;20(1):241.
   PubMed Web of Science ®Google Scholar
• Yin Y, Hong S, Yu S, et al. MiR-195 inhibits tumor growth and metastasis in papillary thyroid carcinoma cell lines by targeting CCND1 and FGF2. Int J Endocrinol. 2017;2017:6180425.
   PubMed Web of Science ®Google Scholar
• Guryanov I, Tennikova T, and Urtti A. Peptide inhibitors of vascular endothelial growth factor A: current situation and perspectives. Pharmaceutics. 2021; 13(9) ;1337.
   PubMed Web of Science ®Google Scholar
• Guo X, Yi H, and Li TC, et al. Role of Vascular Endothelial Growth Factor (VEGF) in human embryo implantation: clinical Implications. Biomolecules. 2021;11(2) ;253.
   PubMed Web of Science ®Google Scholar
• Ren S, Tan X, Fu MZ, et al. Downregulation of miR-375 contributes to ERBB2-mediated VEGFA overexpression in esophageal cancer. J Cancer. 2021;12(23):7138–7146.
   PubMed Web of Science ®Google Scholar
• Ciccarese C, Iacovelli R, Porta C, et al. Efficacy of VEGFR-TKIs plus immune checkpoint inhibitors in metastatic renal cell carcinoma patients with favorable IMDC prognosis. Cancer Treat Rev. 2021;100:102295.
   PubMed Web of Science ®Google Scholar
• Wang R, Ma Q, Ji L, et al. miR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma. Onco Targets Ther. 2018;11:1501–1509.
   PubMed Web of Science ®Google Scholar
• Looi QH, Foo JB, Lim MT, et al. How far have we reached in development of effective influenza vaccine? Int Rev Immunol. 2018;37(5):266–276.
   PubMed Web of Science ®Google Scholar
• Yu AM, Tu MJ. Deliver the promise: rNAs as a new class of molecular entities for therapy and vaccination. Pharmacol Ther. 2021;107967. doi:10.1016/j.pharmthera.2021.107967
   PubMed Web of Science ®Google Scholar